SCHEMBL30425545

SCHEMBL30425545

FC(F)c1nnc(-c2ccc(Cn3cc(-c4ccc5nc(Cl)[nH]c5c4)nn3)cc2)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 5/20 0.53
▸ GSK3B P49841 9/20 0.44
▸ ROCK2 O75116 9/20 0.44
▸ AURKB Q96GD4 6/20 0.44
▸ PIM1 P11309 6/20 0.44
▸ KDR P35968 5/20 0.44
▸ CDC7 O00311 4/20 0.43
▸ ESRRG P62508 1/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ CDK2 P24941 4/20 0.40
▸ JAK2 O60674 3/20 0.40
▸ PRKACA P17612 3/20 0.40
▸ AURKA O14965 2/20 0.40
▸ CHUK O15111 2/20 0.40
▸ MAPK13 O15264 2/20 0.40
▸ DAPK3 O43293 2/20 0.40
▸ CHEK2 O96017 2/20 0.40
▸ PRKCG P05129 2/20 0.40
▸ CDK1 P06493 2/20 0.40
▸ FGFR1 P11362 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25251038 1.00 HDAC6 (0.53) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL30424865 0.88 HDAC6 (0.50) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL25211647 0.88 HDAC6 (0.50) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL25241519 0.86 HDAC6 (0.51) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL25267504 0.86 HDAC6 (0.51) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL25214498 0.85 HDAC6 (0.50) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL25350232 0.83 HDAC6 (0.57) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL25352086 0.83 HDAC6 (0.53) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL25215233 0.82 HDAC6 (0.52) HDAC6GSK3BROCK2AURKBPIM1
SCHEMBL30424426 0.82 HDAC6 (0.52) HDAC6GSK3BROCK2AURKBPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN claimed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN claimed
CN-116157398-B Oxadiazole-based selective histone deacetylase 6 inhibitors 意大发马克股份公司 2025-03-11 — — CN disclosed
CN-116157398-A 2- (4- ((5- (benzo [ b ] thiophen-3-yl) -1H-tetrazol-1-yl) methyl) phenyl) -5- (difluoromethyl) -1,3, 4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (HDAC 6) for the treatment of, for example, peripheral neuropathy 意大发马克股份公司 2023-05-23 — — CN disclosed
Send feedback